Strategic Expansion Hovione has recently invested over 100 million dollars to expand its manufacturing facilities in East Windsor, New Jersey, signaling a focus on increasing production capacity and accommodating growing client demands in the United States market, which offers significant sales opportunities.

Innovative Technology With leadership in specialty technologies such as Spray Drying and Continuous Tableting, Hovione demonstrates a commitment to advanced pharmaceutical manufacturing solutions, presenting opportunities to collaborate with companies seeking cutting-edge drug development and manufacturing capabilities.

Robust Financials Having generated over 10 billion dollars in revenue, Hovione's strong financial position indicates a stable platform for forming long-term partnerships across various phases of drug development, from early-stage formulation to commercial manufacturing.

Global Presence Hovione's international footprint and diverse team of over 2,600 employees across Europe, the US, and Asia facilitate access to regional markets, enabling sales initiatives targeted at multinational pharmaceutical companies seeking localized or global manufacturing solutions.

Industry Engagement Active participation in key industry events like CPHI China, INTERPHEX Tokyo, and organic research conferences highlights Hovione's commitment to innovation and networking, providing avenues for introducing new service offerings and establishing strategic alliances with innovative pharma partners.